This topic contains a solution. Click here to go to the answer

Author Question: One difficulty of repeated-measures designs is that, due to the possibility of fatigue, practice, or ... (Read 112 times)

joesmith1212

  • Hero Member
  • *****
  • Posts: 549
One difficulty of repeated-measures designs is that, due to the possibility of fatigue, practice, or carryover, the researcher may need to use
 
  a. the ANOVA.
  b. random assignment to conditions.
  c. extra statistical power.
  d. counterbalancing.

Question 2

Which of the following is NOT a disadvantage of repeated-measures designs over between-participant designs?
 
  a. The potential for carryover effects
  b. The potential for practice and fatigue effects
  c. The potential for lowered statistical power
  d. The potential for guessing the hypothesis



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

popopong

  • Sr. Member
  • ****
  • Posts: 307
Answer to Question 1

d

Answer to Question 2

c




joesmith1212

  • Member
  • Posts: 549
Reply 2 on: Jun 19, 2018
Gracias!


Hdosisshsbshs

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

For a complete list of videos, visit our video library